⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 27, 2026Liver International

Non‐Selective Beta‐Blockers and Portal Vein Thrombosis in Cirrhosis: Before We Sound the Alarm

Anderson Brito‐Azevedo Ubiratan Cassano-Santos

View Full Paper

Ask AI

Bookmark

Share

Key Points

Assess the relationship between non-selective beta-blocker use and portal vein thrombosis in cirrhosis patients.
Analysis of patient data regarding the use of non-selective beta-blockers.
Evaluation of incidence of portal vein thrombosis in cirrhosis cases.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Non-randomized examination reveals potential associations between beta-blockers and thrombosis in cirrhosis, suggesting caution.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Brito‐Azevedo et al. (2026) studied this question.

synapsesocial.com/papers/6a192da0fab5b468c44167d7 https://doi.org/10.1111/liv.70704

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Nonselective beta-blocker therapy: a potential risk factor for posthepatectomy portal vein thrombosis in cirrhotic patients2025
2Portal Vein Thrombosis Risk in Cirrhotic Patients With Portal Hypertension on Beta‐Blockers: A Multi‐Institutional Cohort StudyRetrospective Study · 2026 · 2 citations
3The Use of Non‐Selective Beta‐Blockers in Cirrhotic Portal HypertensionReview · 2026
4Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity?cohort · 2022 · 5 citations
5Comparison of the Effects of A Cardioselective and A Nonselective β–Blocker on Portal Hypertension in Patients With Cirrhosisother · 1982 · 149 citations